Risk of lymphoma: inflammatory bowel disease and immunomodulators
- PMID: 16531538
- PMCID: PMC1856179
Risk of lymphoma: inflammatory bowel disease and immunomodulators
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.Gut. 2005 Aug;54(8):1121-5. doi: 10.1136/gut.2004.049460. Gut. 2005. PMID: 16009685 Free PMC article.
References
-
- Lewis J D, Bilker W B, Brensinger C.et al Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 20011211080–1087. - PubMed
-
- Karlen P, Lofberg R, Brostrom O.et al Increased risk of cancer in ulcerative colitis: a population‐based cohort study. Am J Gastroenterol 1999941047–1052. - PubMed
-
- Palli D, Trallori G, Bagnoli S.et al Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000119647–653. - PubMed
-
- Bernstein C N, Blanchard J F, Kliewer E.et al Cancer risk in patients with inflammatory bowel disease. Cancer 200191854–862. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical